The IFCC reference measurement system for HbA1c: A 6-year progress report

Clinical Chemistry

Volumn 54, Issue 2, 2008, Pages 240-248

  Weykamp, Cas ^a   John, W Garry ^b   Mosca, Andrea ^c   Hoshino, Tadao ^d   Little, Randie ^e   Jeppsson, Jan Olof ^f   Goodall, Ian ^g   Miedema, Kor ^h   Myers, Gary ⁱ   Reinauer, Hans ^j   Sacks, David B ^k   Slingerland, Robbert ^h   Siebelder, Carla ^a  

^a Queen Beatrix Hospital   (Netherlands)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MILAN   (Italy)

^d Institute of Biopathological Medicine   (Japan)

^e University of Missouri   (United States)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g AUSTIN HEALTH   (Australia)

^h ISALA HOSPITAL   (Netherlands)

ⁱ CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^j Instand eV   (Germany)

^k BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ARTICLE; CALIBRATION; CALIBRATOR; CONTROL; MASS SPECTROMETRY; MEASUREMENT;

BIAS (EPIDEMIOLOGY); CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLINICAL CHEMISTRY TESTS; ELECTROPHORESIS, CAPILLARY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LINEAR MODELS; MASS SPECTROMETRY; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; UNCERTAINTY;

EID: 39749107290     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.097402     Document Type: Article

References (22)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. ADA. Clinical practice guidelines 2007. Diabetes Care 2007;30(Suppl 1):S3.
3. Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE. The national Glycohemoglobin Standardization Program: a five-year progress report. Clin Chem 2001;47:1985-92.
4. Shima K, Endo J, Oimomi M, Oshima I, Omori Y, Katayama Y, et al. Inter-laboratory difference in HbA1c measurement in Japan: a report of the Committee on an Inter-laboratory Standardization of HbA1c Determination, the Japan Diabetes Society. J JPN Diabetes Soc 1994;37:855-64.
5. Arnquist H, Wallensteen M, Jeppsson JO. Standardization of long-term glucose measurements established. Lakartidningen 1997;50:4789-90.
6. Mueller MM. Implementation of reference systems in laboratory medicine. Clin Chem 2000;46:1907-9.
7. Panteghini M, Forest JC. Standardization in laboratory medicine: new challenges [review]. Clin Chim Acta 2005;355:1-12.
8. International Organization for Standardization. In vitro diagnostic medical devices-measurement of quantities in samples of biological origin-metrological traceability of values assigned to calibrators and control material. ISO 17511. Geneva, Switzerland: ISO, 2003.
9. Directive 98/79/EC of the Eurean Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Off J L 1998;331:1-37.
10. Hoelzel W, Miedema K. Development of a reference system for the international standardisation of HbA1c/glycohemoglobin determinations. J Int Fed Clin Chem 1996;9:62-7.
11. Finke A, Kobold U, Hoelzel W, Weykamp C, Jeppsson JO, Miedema K. Preparation of a candidate primary reference material for the international standardisation of HbA1c determinations. Clin Chem Lab Med 1998;36:299-308.
12. Kobold U, Jeppsson JO, Duelffer T, Finke A, Hoelzel W, Miedema K. Candidate reference methods for HbA1c based on peptide mapping. Clin Chem 1997;43:1944-51.
13. Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, et al. Approved IFCC Reference Method for the measurement of HbA1c in human blood. Clin Chem Lab Med 2002;40:78-89.
14. Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr J, Goodall I, et al. IFCC Reference System for measurement of hemoglobin A1c in human blood and the National Standardization Schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004;50:166-74.
15. Consensus Statement on the Worldwide Standardization of the Hemoglobin A1c Measurement. American Diabetes Association, Eurean Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine and International Diabetes Federation Consensus Committee. Diabetes Care 2007;30:2399-400.
16. Hoshino T, Nakayama T, Kuwa K, Nakanishi T, Okahashi M, Tominaga M, et al. Reference method for St-GHbA1c determination: standard operating procedure, Ver. 1.4. Tokyo, Japan: Japanese Society of Clinical Chemistry Working Group on SOP for St-GHbA1c Determination, 2000.
17. Goldstein DE, Little RR, England JD, Wiedmeyer HM, McKenzie EM. Methods for quantitating glycosylated hemoglobins: high performance liquid chromatography and thiobarbituric acid colorimetry: In: Clarke WL, Larner, Pohl S, eds. Methods in diabetic research. Vol 2. Clinical methods. New York: John Wiley, 1986:475-504.
18. Konnert A, Arends S, Schubert S, Berding C, Weykamp C, Siebelder C. Uncertainty calculation for calibrators of the IFCC HbA1c Standardization Network. Accred Qual Assur 2006;11:319-28.
19. Konnert A, Berding C, Arends S, Parvin C, Rohlfing C, Wiedmeyer H, Little R, Siebelder C, Weykamp C. Statistical rules for laboratory networks. J Test Eval 2006;34:128-34.
20. Stöckl D, Reinauer H. Development of criteria for the evaluation of reference method values. Scand J Clin Invest 1993;53 Suppl 212:16-8.
21. Goodall I, Colman P, Schneider H, McLean M, Barber G. Desirable performance standards for HbA1c analysis: precision, accuracy and standardisation. Clin Chem Lab Med 2007;45(8): 1083-97.
22. Kaiser P, Akerboom T, Dux L, Reinauer H. Modification of the IFCC reference measurement procedure for determination of HbA1c by HPLC-ESIMS. GMS Ger Med Sci 2006;4:Doc06.